Literature DB >> 27737508

The effect of arterial hypertension on thrombosis in low-risk polycythemia vera.

Tiziano Barbui1, Alessandro M Vannucchi2, Alessandra Carobbio1, Elisa Rumi3, Guido Finazzi4, Heinz Gisslinger5, Marco Ruggeri6, Maria Luigia Randi7, Mario Cazzola3, Alessandro Rambaldi4, Bettina Gisslinger5, Lisa Pieri2, Juergen Thiele8, Animesh Pardanani9, Ayalew Tefferi9.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 27737508     DOI： 10.1002/ajh.24583

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  13 in total

1.  Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis.

Authors:  Alessandra Carobbio; Alberto Ferrari; Arianna Masciulli; Arianna Ghirardi; Giovanni Barosi; Tiziano Barbui
Journal:  Blood Adv       Date:  2019-06-11

Review 2.  Risk Factors for and Management of MPN-Associated Bleeding and Thrombosis.

Authors:  Karlyn Martin
Journal:  Curr Hematol Malig Rep       Date:  2017-10       Impact factor: 3.952

Review 3.  What are the current treatment approaches for patients with polycythemia vera and essential thrombocythemia?

Authors:  Alessandro M Vannucchi; Paola Guglielmelli
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

4.  From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms.

Authors:  Brady L Stein; Karlyn Martin
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

5.  Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 study.

Authors:  Yoko Edahiro; Tomoki Ito; Akihiko Gotoh; Mika Nakamae; Fumihiko Kimura; Michiaki Koike; Keita Kirito; Hideho Wada; Kensuke Usuki; Takayuki Tanaka; Takehiko Mori; Satoshi Wakita; Toshiki I Saito; Akiko Kada; Akiko M Saito; Kazuya Shimoda; Yuka Sugimoto; Toshiro Kurokawa; Akihiro Tomita; Yoshinori Hashimoto; Koichi Akashi; Itaru Matsumura; Katsuto Takenaka; Norio Komatsu
Journal:  Int J Hematol       Date:  2022-07-09       Impact factor: 2.319

Review 6.  Polycythemia vera treatment algorithm 2018.

Authors:  Ayalew Tefferi; Alessandro M Vannucchi; Tiziano Barbui
Journal:  Blood Cancer J       Date:  2018-01-10       Impact factor: 11.037

Review 7.  MPN: The Molecular Drivers of Disease Initiation, Progression and Transformation and their Effect on Treatment.

Authors:  Julian Grabek; Jasmin Straube; Megan Bywater; Steven W Lane
Journal:  Cells       Date:  2020-08-14       Impact factor: 6.600

8.  Thromboembolic events in polycythemia vera.

Authors:  Martin Griesshammer; Jean-Jacques Kiladjian; Carlos Besses
Journal:  Ann Hematol       Date:  2019-03-08       Impact factor: 3.673

Review 9.  A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: A British Society for Haematology Guideline.

Authors:  Mary F F McMullin; Adam J Mead; Sahra Ali; Catherine Cargo; Frederick Chen; Joanne Ewing; Mamta Garg; Anna Godfrey; Steven Knapper; Donal P McLornan; Jyoti Nangalia; Mallika Sekhar; Frances Wadelin; Claire N Harrison
Journal:  Br J Haematol       Date:  2018-11-13       Impact factor: 6.998

Review 10.  Hematological Malignancies and Arterial Thromboembolism.

Authors:  Nathan Visweshwar; Michael Jaglal; Lubomir Sokol; Benjamin Djulbegovic
Journal:  Indian J Hematol Blood Transfus       Date:  2019-01-28       Impact factor: 0.900
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.